Enoxaparin Weight-Based Dosing

Applies FDA Lovenox label dosing for subcutaneous enoxaparin by indication (weight-based treatment of DVT/PE, fixed-dose prophylaxis), with a mandatory renal dose reduction in renal impairment; label-based decision support, not a prescription.